Glufosfamide is under clinical development by Eleison Pharmaceuticals and currently in Phase III for Metastatic Adenocarcinoma of The Pancreas. According to GlobalData, Phase III drugs for Metastatic ...
Copyright © 2025 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.